Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the commercial launch of BYOOVIZ® (ranibizumab-nuna), an FDA-approved biosimilar ...
Internationally acclaimed artist Refik Anadol will illuminate the Castle's iconic red sandstone façade with AI-generated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results